Japanese Government Procurement
National Hospital Organization - Notice on the use of single tendering procedures①ONDEXXYA for Intravenous Injection 200mg,②ELAPRASE for I.V.Infusion 6mg,③ULTOMIRIS for Intravenous Infusion 300mg,④ONPATTRO Infusion 2mg,⑤ILARIS solution for s.c.injection 150mg,⑥ULTOMIRIS for Intravenous Infusion 1100mg,⑦AMVUTTR Subcutaneous Injection Syringe 25mg,⑧SPINRAZA Intrathecal injectio...
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
| Publishing date | Nov 21, 2023 |
|---|---|
| Type of notice | Notice on the use of single tendering procedures |
| Procurement entity | National Hospital Organization - Nagasaki |
| Classification |
0004 Medical & Pharmaceutical Products |
| Summay of notice | ⑴ Official in charge of disbursement of the procuring entity : Hiroshi Yatsuhashi Director National Hospital Organization Nagasaki Medical Center ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : ① ONDEXXYA for Intravenous Injection 200mg ② ELAPRASE for I.V.Infusion 6mg ③ ULTOMIRIS for Intravenous Infusion 300mg ④ ONPATTRO Infusion 2mg ⑤ ILARIS solution for s.c.injection 150mg ⑥ ULTOMIRIS for Intravenous Infusion 1100mg ⑦ AMVUTTR Subcutaneous Injection Syringe 25mg ⑧ SPINRAZA Intrathecal injection 12mg ⑷ Expected date of the contract award : October 1, 2023 ⑸ Reasons for the use of single tendering procedures as provided for in the Agreement on Government Procurement : b "Protection of Exclusive Rights" ⑹ Contact point for the notice : Hiroshi Tsuyama, Director, Accounting Division, National Hospital Organization Nagasaki Medical Center 2-1001-1Kubara Omura-shi Nagasaki-ken 856-8562, Japan. TEL 0957-52-3121 ext8027 |
